Kefah Mokbel

Oncology — The Princess Grace Hospital, United Kingdom

LeadR Profile

Kefah Mokbel The Princess Grace Hospital United Kingdom
1 735 ScienceLeadR Reputation 1735
Network Map

Oncology

Subspecialties: Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2026

Source: PubMed

The Princess Grace Hospital

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 454

Citations

Citations: 7 918 1st author: 52 Last author: 315 Unique author: 25


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Axillary De-Escalation After Neoadjuvant Therapy in cN2/N3 HER2-Positive and Triple-Negative Breast Cancer: Navigating Biological Promise and Clinical Uncertainty.
triple negative breast neoplasms, lymph nodes, breast neoplasms, neoplasms, multiple chronic conditions, uncertainty, lymph, breast, neoadjuvant therapy, therapeutics, sentinel lymph node biopsy, dissection
Cancers (Basel)20260
Triple-Negative Transformation in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: Tissue Versus Liquid Biopsy in Two Cases.
epidermal growth factor, growth, breast neoplasms, neoplasms, biopsy, hormones, receptors, growth factor, breast, precision medicine, tissues, liquid biopsy
JCO Precis Oncol20260
Breast-Conserving Surgery in Multicentric Breast Cancer: Evolving Evidence and Patient Selection.
mastectomy, breast neoplasms, neoplasms, magnetic resonance imaging, breast, therapeutics
Cancers (Basel)20260
Targeted axillary dissection versus sentinel lymph node biopsy after neoadjuvant chemotherapy: are we underestimating the clinical significance of staging accuracy?
lymph nodes, sentinel lymph node, biopsy, drug therapy, lymph, sentinel lymph node biopsy, dissection, chemotherapy
Transl Breast Cancer Res20260
MRI-guided de-escalation in HER2-positive early breast cancer: precision progress with necessary prudence.
breast neoplasms, neoplasms, breast, neoadjuvant therapy
Transl Breast Cancer Res20260

LeadR Networks

Main global connection map